Similar Items: Glucagon-Like Peptide-1 Receptor Agonists: Their Potential Role in Prediabetes
- Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists in patients without obesity: a systematic review and meta-analysis of randomized controlled trials
- Integrated Evidence from VigiBase and Clinical Trials: A Comprehensive Pharmacovigilance Analysis of Seven Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs)
- of with prediabetes and diabetes in older adults
- Comment on “Lower glycemic status was associated with pancreatic cancer risk in prediabetes”
- Clinical Implications of the 2025–2030 Dietary Guidelines for Americans for Diabetes and Prediabetes Management
- Impact of Cardiometabolic Risk Markers on the Incidence and Progression Arterial Stiffness in Patients With Prediabetes